<DOC>
	<DOCNO>NCT00089804</DOCNO>
	<brief_summary>The primary purpose study determine whether abetimus sodium effective placebo delay time renal flare SLE patient history renal disease .</brief_summary>
	<brief_title>Study LJP 394 Lupus Patients With History Renal Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<criteria>Diagnosis Systemic Lupus Erythematosus ( SLE ) Active SLE renal disease within past 4 year . Males females 12 70 year old . Females must nonpregnant nonlactating . Females male must use adequate birth control method course study . Ability weekly intravenous ( IV ) administration study treatment . Active SLE renal disease within past 3 month prior enter study . Use follow therapy within 3 month prior enter study : alkylating agent , e.g. , cyclophosphamide , TNF inhibitor , cyclosporine . Use mycophenolate mofetil exceed 1000 mg/day , azathioprine exceed 100 mg/day , methotrexate exceeds 10 mg/week , leflunomide exceed 10 mg/day within 2 month prior enter study . Use rituximab within 6 month prior enter study . Current abuse drug alcohol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Lupus</keyword>
	<keyword>Nephritis</keyword>
	<keyword>Kidney</keyword>
	<keyword>SLE</keyword>
	<keyword>Systemic Lupus Erythematosus</keyword>
	<keyword>Nephritis , Lupus</keyword>
</DOC>